Opinion: After 75 years, the best is yet to come for French Hospital in SLO
By Alan Iftiniuk After one of the most challenging years the health care industry has ever faced due to the COVID-19 pandemic, French Hospital Medical Center has reason to celebrate. The facility has reached a significant milestone: serving the community of San Luis Obispo County for 75 years. In 1946, Edison French, MD, set out Read More →
Care homes face uncertain future as they emerge from pandemic
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Even without a government mandate, some businesses still requiring masks
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
FDA accuses Amgen of misleading advertising
The U.S. Food and Drug Administration tagged Amgen with a letter July 7 that says the Thousand Oaks biotech firm made “misleading claims” in advertisements for its drug Neulasta, by suggesting it is more effective than biosimilar competitors. Neulasta is a prescription medication used to reduce infection risk from febrile neutropenia (a low level of Read More →
A century of Central Coast health
Despite vaccines, a drop in infectious rates and cities shifting from protective health measures to preventative approaches, 2021 resumes the two-year trend of health care as a focal issue in the U.S., as cities direct what they hope to be the COVID’s third and final act. With hospitals and clinics already in their communities’ spotlight, Read More →
FDA gives Amgen priority review for asthma treatment
Thousand Oaks-based Amgen received a priority review for tezepelumab, a treatment for asthma, from the U.S. Food and Drug Administration, the biotech giant announced July 7. According to Amgen, tezepelumab is the first and only biologic to consistently and significantly reduce asthma exacerbations in a broad population of clients in phase 2 and 3 trials. Read More →
Cities, counties wind down COVID enforcement cases
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
